Search results
Results from the WOW.Com Content Network
Impetigo herpetiformis is a form of severe pustular psoriasis occurring in pregnancy [1] [2] which may occur during any trimester. [ 3 ] [ 4 ] Signs and symptoms
Cutaneous manifestations of COVID-19 are characteristic signs or symptoms of the Coronavirus disease 2019 that occur in the skin. The American Academy of Dermatology reports that skin lesions such as morbilliform (measles-like rashes, 22%), pernio (capillary damage, 18%), urticaria (hives, 16%), macular erythema (rose-colored rash, 13%), vesicular purpura (purplish discolouration, 11% ...
What Pregnant Women Need to Know About the Coronavirus
Impetigo is a contagious bacterial infection that involves the superficial skin. [2] The most common presentation is yellowish crusts on the face, arms, or legs. [ 2 ] Less commonly there may be large blisters which affect the groin or armpits . [ 2 ]
A systematic review update in 2022 demonstrated that pregnant women are at increased risk of severe COVID-19. It also found that risk factors for severe COVID-19 in pregnant people included high body mass index, being of an older age, being of non-white ethnic origin, having pre-existing comorbidities, having pre-eclampsia or gestational diabetes.
Bullous impetigo is a bacterial skin infection caused by Staphylococcus aureus that results in the formation of large blisters called bullae, usually in areas with skin folds like the armpit, groin, between the fingers or toes, beneath the breast, and between the buttocks.
A June 2020 systematic review found a 29–54% prevalence of olfactory dysfunction for people with COVID-19, [59] while an August 2020 study using a smell-identification test reported that 96% of people with COVID-19 had some olfactory dysfunction, and 18% had total smell loss. [60]
Lateral flow assays have played a critical role in COVID-19 testing as they have the benefit of delivering a result in 15–30 minutes. [31] The systematic evaluation of lateral flow assays during the COVID-19 pandemic [32] was initiated at Oxford University as part of a UK collaboration with Public Health England. A study that started in June ...